News

ASCEND-HF study showed that Natrecor demonstrated no difference from placebo in the co-primary endpoints of dyspnea, measured at six and 24 hours, or in the composite of heart

Macugen, a selective inhibitor of VEGF-165, is approved for the treatment of neovascular age-related macular degeneration (neovascular AMD), which is expected to decrease the frequency of dosing from

Most recently, Kelly worked as the vice president and controller at MedImmune, and joined MedImmune as director of Sales and Marketing Finance and progressed to the role of

NovaDel Pharma’s loss from operations was $1.52m, compared to $1.28m for the comparable period in 2009. For the nine months ended 30 September 2010, NovaDel has posted a

Bohai Pharma has posted a net income of $3m for the first quarter 2010, or $0.15 per diluted share, compared to net income of $1.9m, or $0.15 per

Collis previously was executive vice president of AmerisourceBergen and president of AmerisourceBergen Drug (ABDC), the company’s largest subsidiary. Prior to that he was executive vice president of AmerisourceBergen

GSK and Fiocruz have established a relationship in 1985 to manufacture vaccines for public health priorities in Brazil. These include polio, Haemophilus influenzae type b (Hib), measles, mumps,

Meda CEO Anders Lonner said that OTC products is a growing segment and the acquisition of OTC brands further strengthens their presence in this area. The aquired products

Ablynx and Boehringer Ingelheim have signed an agreement in September 2007 to collaborate on the discovery, development and commercialisation of up to 10 different Nanobody therapeutics across areas